FDA update on AstraZeneca heartburn drugs seen
in [Heart Medication]
|
Prev: How to Manage Refractory Gastroesophageal Reflux Disease CME
Next: Black Raspberries May Protect Against Esophageal Cancer (Barrett's esophagus)
From: Vanny on 7 Dec 2007 10:30 FDA update on AstraZeneca heartburn drugs seen " By Kim Dixon WASHINGTON (Reuters) - U.S. regulators are likely to update the public within days about any potential heart risks of AstraZeneca Plc's stomach-acid drugs, which are taken by more than 1 billion people worldwide. In early August, the U.S. Food and Drug Administration and Health Canada said they were studying the cardiac impact of Prilosec and Nexium. The agencies at the time cited two studies suggesting an association with greater risk of heart attacks, heart failure and heart-related sudden death when compared with surgery. However, the FDA's own initial analyses did not show a higher heart risk, and both agencies told doctors not to change prescribing practices."... More here: http://www.reuters.com/article/healthNews/idUSN0622067220071206 |